Oshkosh stock hits all-time high of 142.0 USD

Oshkosh (NYSE:OSK) Corporation’s stock has reached a significant milestone, hitting an all-time high of 142.0 USD, marking an impressive 46.26% gain year-to-date. According to InvestingPro data, the company maintains a GREAT financial health score, with analysts setting price targets up to $188. This achievement reflects a robust 32.29% increase over the past year, underscoring the company’s strong performance and investor confidence. The stock’s impressive rise comes amid a backdrop of strategic initiatives and market conditions that have favored Oshkosh’s growth trajectory. Trading at a P/E ratio of 14.1x and showing slight undervaluation based on InvestingPro’s Fair Value model, the company has maintained dividend payments for 13 consecutive years. As the company continues to innovate and expand its market presence, investors are closely watching how these factors will influence future valuations. For deeper insights, access the comprehensive Pro Research Report available on InvestingPro, along with 10 additional exclusive ProTips for OSK.

In other recent news, Oshkosh has reported strong second-quarter earnings, leading to several analysts raising their price targets for the company. UBS increased its price target to $164, citing higher profits and margins across all business segments. DA Davidson also raised its target to $160, noting improvements in Oshkosh’s Access segment. Raymond (NSE:RYMD) James set a new target of $155, highlighting the company’s adjusted earnings per share of $3.41, which exceeded their expectations. Bernstein raised their target to $132, acknowledging that the earnings surpassed consensus estimates by 16%.

KeyBanc reiterated its Overweight rating with a $140 price target, expressing confidence in Oshkosh’s progress toward its 2028 goals. The firm noted that the company raised its guidance to $11.00, removing a previously anticipated $0.50 tariff impact. These developments reflect a positive outlook from analysts following Oshkosh’s recent performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.